Literature DB >> 4335071

In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus.

G L Rosenberg, P A Farber, A L Notkins.   

Abstract

Splenic lymphocytes from rabbits immunized with herpes simplex virus (HSV) were incubated in vitro with ultraviolet light-inactivated HSV, and the degree of lymphocyte transformation was determined by measurement of the incorporation of [(3)H]thymidine into acid-insoluble material. Lymphocytes from immunized rabbits were stimulated as much as 30-fold, whereas lymphocytes from control rabbits were unaffected. Lymphocyte sensitization occurred within 3 days after immunization; sensitized lymphocytes could still be detected 120 days after immunization. The antigenicity of the ultraviolet light-inactivated crude virus pool was found to reside primarily in the virion. Infectious virus, in comparison with inactivated virus, produced less lymphocyte stimulation. Studies on the interaction of the humoral and cellular immune responses showed that incubation of anti-HSV antibody with HSV antigens did not reduce the capacity of the viral antigens to stimulate sensitized lymphocytes. Other experiments revealed that lymphocytes from both the spleen and peripheral blood of animals immunized with vaccinia virus could be stimulated by vaccinia, but not by HSV. Conversely, lymphocytes from animals immunized with HSV could not be stimulated by vaccinia. The transformation of sensitized lymphocytes by viral antigens appears to be a simple, highly specific, and quantitative in vitro technique for the study of the cellular immune response to viral infections.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4335071      PMCID: PMC426551          DOI: 10.1073/pnas.69.3.756

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  An immuno-cytopathogenic interaction between sensitized leukocytes and epithelial cells carrying a persistent noncytocidal myxovirus infection.

Authors:  L F Speel; J E Osborn; D L Walker
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

2.  Viral inhibition of the phytohemagglutinin response of human lymphocytes and application to viral hepatitis.

Authors:  F T Willems; J L Melnick; W E Rawls
Journal:  Proc Soc Exp Biol Med       Date:  1969-02

3.  An in vitro measure of cellular immunity to fibroma virus.

Authors:  W A Tompkins; C Adams; W E Rawls
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

4.  Relationship of in vitro lymphocyte transformation to delayed hypersensitivity in guinea pigs and man.

Authors:  J J Oppenheim
Journal:  Fed Proc       Date:  1968 Jan-Feb

5.  Induction of delayed hypersensitivity to influenza and mumps viruses in mice.

Authors:  S M Feinstone; E H Beachey; M W Rytel
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

6.  Macrophage-lymphocyte interaction in the antigen-induced blastogenic response of human peripheral blood leukocytes.

Authors:  E M Hersh; J E Harris
Journal:  J Immunol       Date:  1968-06       Impact factor: 5.422

7.  Smallpox vaccination of eczema patients with a strain of attenuated live vaccinia (CVI-78).

Authors:  C H Kempe; V Fulginiti; M Minamitani; H Shinefield
Journal:  Pediatrics       Date:  1968-12       Impact factor: 7.124

8.  Replication of mumps virus in human leukocyte cultures.

Authors:  H Duc-Nguyen; W Henle
Journal:  J Bacteriol       Date:  1966-07       Impact factor: 3.490

9.  Specific role of each human leukocyte type in viral infections. II. Phytohemagglutinin-treated lymphocytes as host cells for vesicular stomatitis virus replication in vitro.

Authors:  R Edelman; E F Wheelock
Journal:  J Virol       Date:  1968-05       Impact factor: 5.103

10.  Abnormalities of in vitro lymphocyte responses during rubella virus infections.

Authors:  G B Olson; P B Dent; W E Rawls; M A South; J R Montgomery; J L Melnick; R A Good
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

View more
  37 in total

Review 1.  The fifth Frederick H. Verhoeff Lecture. The role of the lymphocyte (cell-mediated) immunity in ocular disease.

Authors:  I H Leopold
Journal:  Trans Am Ophthalmol Soc       Date:  1973

2.  The essentials of data sources in eye epidemiology.

Authors:  T Tokumaru; S Austin-Sweeney
Journal:  Doc Ophthalmol       Date:  1976-03-31       Impact factor: 2.379

3.  Stimulation of human lymphocytes by Herpes simplex virus antigens.

Authors:  S E Starr; S A Karatela; S L Shore; A Duffey; A J Nahmias
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

4.  Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1.

Authors:  I Heron; A Moller-Larsen; K Berg
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

5.  Cell-mediated immunity assayed by 51Cr release test in mice infected with mouse adenovirus.

Authors:  T Inada; H Uetake
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

6.  Lymphocyte and macrophage responses after vaccinia virus infections.

Authors:  C McLaren; H Cheng; D L Spicer; W A Tompkins
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

Review 7.  Mechanisms of recovery from Herpesvirus infections -a review.

Authors:  B T Rouse; L A Babiuk
Journal:  Can J Comp Med       Date:  1978-10

8.  Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody.

Authors:  G H Cohen; M Ponce de Leon; C Nichols
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

9.  Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virus.

Authors:  A Møller-Larsen; S Haahr
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

10.  In vitro studies on the mechanism of herpesvirus plaque growth inhibition by sensitized lymphocytes.

Authors:  Y M Centifanto; Z S Zam; H E Kaufman
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.